Valuation (16%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -1.35 | -18.94 |
| PEG Ratio (TTM) | -0.27 | -5.61 |
| P/S Ratio (TTM) | 59.23 | 47.90 |
| P/B Ratio (TTM) | 0.86 | 30.89 |
| P/FCF Ratio (TTM) | -1.41 | -6.05 |
| Price to 5YR AVG Earnings Ratio | -1.08 | -5.69 |
| Price to 5YR AVG FCF Ratio | -1.33 | -13.62 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -56.10% | -17.89% |
| ROE (TTM) | -55.66% | 28.85% |
| Net Profit Margin (TTM) | -4,365.35% | -540.96% |
| ROIC 5YR AVG | -84.56% | -3.04% |
Growth (15%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 3.76% | -2,516.13% | -1,513.96% |
| Revenue | -63.77% | -10.40% | -30.43% |
| Net Income | 3.35% | -1,977.15% | -1,192.14% |
| Cash Flow | 3.55% | -177.49% | -124.25% |
Health (32%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 7.79 | 5.75 |
| Quick Ratio (TTM) | 7.79 | 5.53 |
| D/E Ratio (TTM) | N/A | 1.08 |
| Interest Coverage (TTM) | -39.76 | -7.40 |
| Piotroski F-Score | 2 | 5 |
| Altman Z-Score | N/A | 13.03 |
| LTL to 5YR AVG FCF | N/A | 0.08 |
| Shares Outstanding Growth 5YR AVG | 6.60% | 40.65% |